Interestingly, the selective knockdown or down-regulation of ANP32A ameliorated the cognitive deficits as well as the synaptic plasticity in different experimental animal models for Alzheimer’s disease (AD) and was discussed as a potential molecular marker for neuroprotection [24,25,26]. Here, ANP32A is linked to Alzheimer disease.